Chart of the Day: A Rectangle Pattern Develops in CRISPR Therapeutics (CRSP)

NASDAQ: CRSP | CRISPR Therapeutics AG News, Ratings, and Charts

CRSP – CRISPR Therapeutics (CRSP), a gene-editing company, has been bouncing back and forth in a rectangle pattern. Learn when to go short or long.

CRISPR Therapeutics (CRSP) is trading in a horizontal channel, also known as a rectangle pattern, and a significant move in the stock is expected soon.

CRSP is a gene-editing company that is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. This technology that can repair defective genetic material has game-changing potential. The lead candidate in its pipeline is CTX001, which is an investigational ex vivo CRISPR gene-edited therapy currently being developed for treating TDT and severe SCD.

Take a look at the 1-year chart of CRSP below with added notations:

Chart of CRSP provided by TradingView

For the past month, CRSP has been in a sideways trading range. While in the range, the stock has formed a key resistance at $97 (red), and an important level of support at $84 (green).

The possible long positions on the stock would be on a breakout above $97. The ideal short opportunity would be on a breakdown below $84.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this presentation to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to learn these patterns and how to quickly find the 5 to 7 best trades today.

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


CRSP shares were trading at $89.67 per share on Friday morning, down $2.07 (-2.26%). Year-to-date, CRSP has gained 47.23%, versus a 5.69% rise in the benchmark S&P 500 index during the same period.


About the Author: christian


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CRSPGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Expert Predicts 3-6 Months of Pain

2 important market developments are leading market expert Steve Reitmeister to predict 3 to 6 months of painful market conditions pushing the S&P 500 (SPY) lower. Read on for the full story...

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more...

3 Tech Stocks Analysts Say Are "Strong Buys" for 2025

The technology industry is well-positioned for significant growth thanks to the rapid advancements in emerging technologies and the digitization of business operations. Amid this backdrop, fundamentally solid tech stocks Adobe (ADBE), Leidos Holdings (LDOS), and DocuSign (DOCU) could be strong buys for 2025. Continue reading...

3 Tech Stocks Under $20 With Breakout Potential

The tech sector is the core of innovation, from transforming industries to powering economic progress. Amid this backdrop, investors could consider buying sound under $20 tech stocks Vimeo (VMEO), PubMatic (PUBM), and Eventbrite (EB). Keep reading…

How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

Read More Stories

More CRISPR Therapeutics AG (CRSP) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRSP News